ALGN Q4 Deep Dive: DSO Expansion and New Products Drive Growth Amid Stable Markets

Dental technology company Align Technology (NASDAQ:ALGN) announced better-than-expected revenue in Q4 CY2025, with sales up 5.3% year on year to $1.05 billion. The company expects next quarter’s revenue to be around $1.02 billion, close to analysts’ estimates. Its non-GAAP profit of $3.29 per share was 10.8% above analysts’ consensus estimates.

Is now the time to buy ALGN? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Align Technology's fourth quarter was met with a positive market response, as management pointed to strong growth in clear aligner volumes and continued momentum within dental service organizations (DSOs). CEO Joe Hogan highlighted that the improved results were driven by record case volumes in Europe, Latin America, and Asia-Pacific, with DSOs in the Americas delivering double-digit year-over-year growth. Hogan noted the company's broadening product portfolio and targeted marketing strategies, which supported both adult and teen patient segments, as key factors behind the volume gains.

Looking ahead, Align Technology's guidance reflects expectations for steady end-market conditions, with management emphasizing international expansion and increased orthodontic utilization among teens and kids. CFO John Morici stated, "We expect Q1 clear aligner volume to be up mid single digits year over year," while Hogan described ongoing product innovation and regional strategies as central to driving adoption. The company plans to continue leveraging DSOs, expanding its AI-driven platforms, and scaling new manufacturing technologies, while remaining cautious about macroeconomic uncertainty and regional pricing dynamics.

Key Insights from Management’s Remarks

Management attributed fourth quarter momentum to increased DSO penetration, robust product adoption across age groups, and expanded international reach, which collectively offset softness in North American retail channels.

• DSO channel momentum: DSOs emerged as a major growth engine, especially in the Americas, with top DSOs achieving double-digit case volume increases. Management sees DSOs as ideal partners for scaling digital workflows and noted their expanding influence in the dental industry.
• International adoption accelerates: Strong aligner volume growth in Europe, Latin America, and Asia-Pacific was supported by tailored regional strategies, local manufacturing, and product offerings designed for specific clinical needs. Notably, Europe and Latin America surpassed key patient treatment milestones.
• Teen and kid segment strength: The Invisalign First and Palate Expander systems drove higher case starts among younger patients, particularly in APAC and Latin America. Doctor engagement for teen and early intervention cases rose, supported by dedicated training and product innovation.
• Product and workflow innovation: Align continued to invest in AI-driven treatment planning, 3D printed appliances, and integrated digital workflows. Early adoption of direct fabrication was reported to be margin dilutive initially but is expected to improve efficiency and lower costs as scale grows.
• North America retail stabilization: While North American retail channels remained pressured by macroeconomic factors, management cited improved stability and better execution, aided by expanded financing options and a broader, more affordable product mix.

Drivers of Future Performance

Align Technology expects steady market trends in 2026, with international growth, enhanced teen engagement, and technology investments guiding its strategy amid ongoing margin management.

• International and DSO expansion: Management believes that deeper partnerships with DSOs and continued international market penetration—especially in Europe, Latin America, and Asia-Pacific—will be pivotal for growth. These channels are expected to outpace traditional retail practices, driving higher adoption of both clear aligners and digital workflows.
• Product innovation and operational scaling: The rollout of new products like 3D printed retainers and expanded AI-powered planning tools is expected to broaden the addressable market. Management indicated that while direct fabrication will initially weigh on margins, scaling production should unlock cost efficiencies by late 2027.
• Margin improvement and risks: The company aims for non-GAAP operating margin expansion through a combination of product mix optimization and productivity gains. However, management cautioned that macroeconomic uncertainty, regional pricing shifts (notably in China), and the pace of new technology adoption could introduce volatility to both revenue and margins.

Catalysts in Upcoming Quarters

Over the coming quarters, the StockStory team will monitor (1) the expansion and performance of DSOs as a core growth channel, (2) adoption and clinical outcomes from new AI-driven and 3D printed products, and (3) progress in international markets, particularly as regional product strategies roll out. Additionally, tracking the scalability of direct fabrication and its impact on margins will be important for assessing longer-term profitability.

Align Technology currently trades at $172.64, up from $161.30 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.

The names generating the next wave of massive growth are right here in our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.